US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LB Pharmaceuticals

47.52

-1.9600-3.96%

Post-market: 47.520.00000.00%16:10 EDT

Volume:282.47K

Turnover:13.44M

Market Cap:1.53B

PE:-15.90

High:48.91

Open:48.88

Low:46.72

Close:49.48

52wk High:50.16

52wk Low:13.36

Shares:32.26M

Float Shares:21.62M

Volume Ratio:0.89

T/O Rate:1.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.9880

EPS(LYR):-3.1329

ROE:-50.00%

ROA:-29.98%

PB:4.61

PE(LYR):-15.17

Loading ...

Overview Company News Filings

LB Pharmaceuticals management to meet with Piper Sandler

LB Pharmaceuticals Price Target Maintained with a $45.00/Share by HC Wainwright & Co.

LB Pharmaceuticals Prices USD 150 Million Private Placement at USD 34.94 Per Share

Lb Pharmaceuticals - Net Proceeds to Fund Lb-102 Pipeline Expansion and General Corporate Purposes

THOMSON REUTERS

Lb Pharmaceuticals Announces $150 Million Private Placement

THOMSON REUTERS

LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained

LB Pharmaceuticals Releases Update on Nova-2 Phase 3 Schizophrenia Trial Timeline

Lb Pharmaceuticals - Topline Data from Phase 2 Trial in Adjunctive Mdd Expected in H1 2029

THOMSON REUTERS

Lb Pharmaceuticals - Expects Cash Runway into Q2 2029

THOMSON REUTERS

Lb Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 Nova-2 Trial of Lb-102 in Schizophrenia

THOMSON REUTERS

Lb Pharmaceuticals - to Report Phase 3 Nova-2 Topline Results in H1 2027

THOMSON REUTERS

Lb Pharmaceuticals - Topline Data from Phase 2 Illuminate-1 in Bipolar Depression Expected in Q1 2028

THOMSON REUTERS

Lb Pharmaceuticals Inc : Bmo Initiates Coverage with Outperform Rating; Target Price $46

THOMSON REUTERS

LB Pharmaceuticals Initiated at Outperform by BMO Capital

LB Pharmaceuticals Grants SVP Zergebel Option for 75,000 Shares at $32.95 Under NASDAQ Inducement Rule

Lb Pharmaceuticals Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Press Release: LB Pharmaceuticals Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(c)(4)

LB Pharmaceuticals Initiated at Outperform by Wolfe Research

Lb Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations

THOMSON REUTERS

Press Release: LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/LBRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","market":"US","secType":"STK","nameCN":"LB Pharmaceuticals","latestPrice":47.52,"timestamp":1788465600000,"preClose":49.48,"halted":0,"volume":282469,"hourTrading":{"tag":"盘后","latestPrice":47.52,"preClose":47.52,"latestTime":"16:10 EDT","volume":1973,"amount":93756.96,"timestamp":1788466205563,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03961196443007263,"floatShares":21621800,"shares":32259175,"eps":-2.988,"marketStatus":"Post-Mkt","change":-1.96,"latestTime":"09-03 18:35:11 EDT","open":48.88,"high":48.91,"low":46.72,"amount":13435248,"amplitude":0.04426,"askPrice":48.21,"askSize":41,"bidPrice":46.89,"bidSize":101,"shortable":3,"etf":0,"ttmEps":-2.988,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788480000000},"marketStatusCode":4,"adr":0,"listingDate":1757563200000,"exchange":"NASDAQ","adjPreClose":49.48,"preHourTrading":{"tag":"盘前","latestPrice":49.5,"preClose":49.48,"latestTime":"09:25 EDT","volume":89,"amount":4460.890752,"timestamp":1788441900017,"change":0.02,"changeRate":0.000404,"amplitude":0.059418},"postHourTrading":{"tag":"盘后","latestPrice":47.52,"preClose":47.52,"latestTime":"16:10 EDT","volume":1973,"amount":93756.96,"timestamp":1788466205563,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.886061,"impliedVol":0.6613,"impliedVolPercentile":0.3676},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","floatShares":21621800,"roa":"-29.98%","roe":"-50.00%","lyrEps":-3.132945,"volumeRatio":0.886061,"shares":32259175,"dividePrice":0,"high":48.91,"amplitude":0.04426,"preClose":49.48,"low":46.72,"week52Low":13.36,"pbRate":"4.61","week52High":50.16,"institutionHeld":0,"latestPrice":47.52,"committee":0.422535,"eps":-2.988,"divideRate":0,"volume":282469,"delay":0,"ttmEps":-2.988,"open":48.88,"prevYearClose":22.26,"prevWeekClose":47.73,"prevMonthClose":47.26,"prevQuarterClose":32.455,"fiveDayClose":47.89,"twentyDayClose":48.18,"sixtyDayClose":29.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"LBRX","fiscalQuarterEnding":"2026/06","expectedEps":-0.84,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-1.71},{"market":"US","date":"2026-05-12","symbol":"LBRX","fiscalQuarterEnding":"2026/03","expectedEps":-0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2026-03-26","symbol":"LBRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1784606400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LBRX","date":"2026-09-02","current":-15.903614,"percent":0.807377,"low":-37.407457,"twenty":-31.972339,"median":-24.610697,"eighty":-17.790454,"high":-0.410019,"avg":-24.132535,"sd":7.541717,"marketCap":1519407142},"quantilePoints":[{"date":"2025-09-12","current":-13.187639,"twenty":-10.632115,"median":-6.798829,"eighty":-2.965543,"marketCap":388099031},{"date":"2025-09-19","current":-12.217088,"twenty":-12.798201,"median":-12.438246,"eighty":-12.070666,"marketCap":359536683},{"date":"2025-09-26","current":-11.40109,"twenty":-12.682283,"median":-12.163705,"eighty":-11.408716,"marketCap":335522685},{"date":"2025-10-03","current":-11.790024,"twenty":-12.394014,"median":-12.03406,"eighty":-11.475827,"marketCap":346968609},{"date":"2025-10-10","current":-11.927294,"twenty":-12.217088,"median":-11.973051,"eighty":-11.471251,"marketCap":351008347},{"date":"2025-10-17","current":-12.506882,"twenty":-12.401641,"median":-12.018808,"eighty":-11.491079,"marketCap":368065019},{"date":"2025-10-24","current":-12.079817,"twenty":-12.247593,"median":-12.026434,"eighty":-11.561239,"marketCap":355496945},{"date":"2025-10-31","current":-12.415368,"twenty":-12.43367,"median":-12.041687,"eighty":-11.652753,"marketCap":365371860},{"date":"2025-11-07","current":-18.511527,"twenty":-12.493155,"median":-12.14464,"eighty":-11.774771,"marketCap":348090759},{"date":"2025-11-14","current":-20.046619,"twenty":-12.715838,"median":-12.201836,"eighty":-11.777822,"marketCap":376956619},{"date":"2025-11-21","current":-21.244034,"twenty":-16.587413,"median":-12.217088,"eighty":-11.811377,"marketCap":399472820},{"date":"2025-11-28","current":-23.934856,"twenty":-18.511527,"median":-12.278098,"eighty":-11.89679,"marketCap":450071024},{"date":"2025-12-05","current":-25.899155,"twenty":-20.625145,"median":-12.354359,"eighty":-11.912042,"marketCap":487007713},{"date":"2025-12-12","current":-27.217658,"twenty":-21.714928,"median":-12.472564,"eighty":-11.927294,"marketCap":511800833},{"date":"2025-12-19","current":-26.50459,"twenty":-23.934856,"median":-12.598395,"eighty":-11.934921,"marketCap":498392309},{"date":"2025-12-26","current":-29.599034,"twenty":-25.317938,"median":-12.735666,"eighty":-11.971526,"marketCap":556580244},{"date":"2026-01-02","current":-29.948841,"twenty":-26.033696,"median":-12.811928,"eighty":-12.003556,"marketCap":563158010},{"date":"2026-01-09","current":-27.984542,"twenty":-26.736001,"median":-17.717835,"eighty":-12.027959,"marketCap":526221321},{"date":"2026-01-16","current":-28.76488,"twenty":-26.943194,"median":-18.511527,"eighty":-12.038636,"marketCap":540894800},{"date":"2026-01-23","current":-31.724783,"twenty":-27.597063,"median":-20.046619,"eighty":-12.056939,"marketCap":596552825},{"date":"2026-01-30","current":-28.482344,"twenty":-28.30475,"median":-20.93459,"eighty":-12.092019,"marketCap":535581989},{"date":"2026-02-06","current":-32.101498,"twenty":-28.673392,"median":-21.418938,"eighty":-12.137776,"marketCap":603636573},{"date":"2026-02-13","current":-32.760749,"twenty":-28.899421,"median":-22.367452,"eighty":-12.188109,"marketCap":616033133},{"date":"2026-02-20","current":-32.558938,"twenty":-29.179266,"median":-23.692682,"eighty":-12.201836,"marketCap":612238268},{"date":"2026-02-27","current":-32.5993,"twenty":-29.599034,"median":-24.876643,"eighty":-12.203361,"marketCap":612997241},{"date":"2026-03-06","current":-31.684421,"twenty":-30.30403,"median":-25.616619,"eighty":-12.210987,"marketCap":595793852},{"date":"2026-03-13","current":-33.554542,"twenty":-31.627914,"median":-25.899155,"eighty":-12.217088,"marketCap":630959603},{"date":"2026-03-20","current":-32.276402,"twenty":-31.988483,"median":-26.370049,"eighty":-12.224714,"marketCap":606925456},{"date":"2026-03-27","current":-24.621582,"twenty":-31.988483,"median":-26.625677,"eighty":-12.26437,"marketCap":620586972},{"date":"2026-04-02","current":-24.902627,"twenty":-31.966957,"median":-26.235508,"eighty":-12.300976,"marketCap":627670720},{"date":"2026-04-10","current":-26.388153,"twenty":-31.886233,"median":-26.156251,"eighty":-12.33148,"marketCap":665113391},{"date":"2026-04-17","current":-28.385582,"twenty":-31.84587,"median":-26.235508,"eighty":-12.354359,"marketCap":715458604},{"date":"2026-04-24","current":-35.011617,"twenty":-31.993865,"median":-26.565134,"eighty":-12.415368,"marketCap":882467800},{"date":"2026-05-01","current":-36.076352,"twenty":-32.168769,"median":-26.669198,"eighty":-12.438246,"marketCap":909304449},{"date":"2026-05-08","current":-36.38353,"twenty":-32.30331,"median":-26.814034,"eighty":-12.506882,"marketCap":917046871},{"date":"2026-05-15","current":-23.123601,"twenty":-32.316764,"median":-26.760218,"eighty":-12.583143,"marketCap":900733639},{"date":"2026-05-22","current":-20.613207,"twenty":-32.30331,"median":-26.667619,"eighty":-12.598395,"marketCap":802946256},{"date":"2026-05-29","current":-20.2672,"twenty":-32.30331,"median":-26.565134,"eighty":-12.6289,"marketCap":789468229},{"date":"2026-06-05","current":-21.275774,"twenty":-32.281784,"median":-26.235508,"eighty":-12.715838,"marketCap":828755242},{"date":"2026-06-12","current":-21.010748,"twenty":-32.254875,"median":-25.973152,"eighty":-12.741767,"marketCap":818431648},{"date":"2026-06-18","current":-22.122388,"twenty":-32.201059,"median":-25.758446,"eighty":-12.784474,"marketCap":861733392},{"date":"2026-06-26","current":-22.821765,"twenty":-32.168769,"median":-25.603165,"eighty":-13.037355,"marketCap":888976212},{"date":"2026-07-02","current":-23.476971,"twenty":-32.141861,"median":-25.394457,"eighty":-14.887526,"marketCap":914498432},{"date":"2026-07-10","current":-24.838915,"twenty":-32.079972,"median":-25.197689,"eighty":-17.661739,"marketCap":967550238},{"date":"2026-07-17","current":-22.519929,"twenty":-32.026155,"median":-24.876643,"eighty":-18.127213,"marketCap":877218784},{"date":"2026-07-24","current":-25.486758,"twenty":-31.993865,"median":-24.857779,"eighty":-18.396949,"marketCap":992785692},{"date":"2026-07-31","current":-30.110006,"twenty":-31.988483,"median":-25.029051,"eighty":-18.623718,"marketCap":1172875066},{"date":"2026-08-07","current":-35.46944,"twenty":-32.036919,"median":-25.243817,"eighty":-19.236335,"marketCap":1381641093},{"date":"2026-08-14","current":-16.667021,"twenty":-32.036919,"median":-25.197689,"eighty":-18.062763,"marketCap":1428113677},{"date":"2026-08-21","current":-17.781418,"twenty":-31.993865,"median":-24.876643,"eighty":-17.822455,"marketCap":1523600835},{"date":"2026-08-28","current":-18.029899,"twenty":-31.988483,"median":-24.686825,"eighty":-17.939919,"marketCap":1544891890},{"date":"2026-09-02","current":-17.732475,"twenty":-31.972339,"median":-24.610697,"eighty":-17.790454,"marketCap":1519407142}],"updateTime":1788474908293},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LBRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658956102","title":"LB Pharmaceuticals management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956102?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:00","pubTimestamp":1786392021,"startTime":"0","endTime":"0","summary":"Meeting to be held in New York on August 17 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-management-to-meet-with-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-management-to-meet-with-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4233","LB","LBRX","BK4007","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656024378","title":"LB Pharmaceuticals Price Target Maintained with a $45.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2656024378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656024378?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:42","pubTimestamp":1785753720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655886045","title":"LB Pharmaceuticals Prices USD 150 Million Private Placement at USD 34.94 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2655886045","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655886045?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:20","pubTimestamp":1785327655,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals prices USD 150 million private placement at USD 34.94 per shareLB Pharmaceuticals priced a USD 150 million private placement of common stock and pre-funded warrants with institution","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL74y1xn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655867089","title":"Lb Pharmaceuticals - Net Proceeds to Fund Lb-102 Pipeline Expansion and General Corporate Purposes","url":"https://stock-news.laohu8.com/highlight/detail?id=2655867089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655867089?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:00","pubTimestamp":1785326402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA6VXJQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655290867","title":"Lb Pharmaceuticals Announces $150 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2655290867","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655290867?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:00","pubTimestamp":1785326402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA6VXJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653721485","title":"LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2653721485","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653721485?lang=en_us&edition=fundamental","pubTime":"2026-07-23 23:25","pubTimestamp":1784820335,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on LB Pharmaceuticals, Inc., with a price target of $45.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/lb-pharmaceuticals-buy-rating-reaffirmed-on-lb-102-clinical-momentum-and-regulatory-progress-45-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/lb-pharmaceuticals-buy-rating-reaffirmed-on-lb-102-clinical-momentum-and-regulatory-progress-45-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653875778","title":"LB Pharmaceuticals Releases Update on Nova-2 Phase 3 Schizophrenia Trial Timeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2653875778","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653875778?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:04","pubTimestamp":1784721878,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals releases update on NOVA-2 Phase 3 schizophrenia trial timelineLB Pharmaceuticals posted a press release accelerating expected topline timing for Phase 3 NOVA-2 data for LB-102 in sc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL7Nm80f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014039.USD","LU2210150020.SGD","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4585","BCDF","BK4588","LU2095319765.USD","SG9999014021.USD","BK4007","LBRX","SG9999014005.SGD","IE00BN0W2W23.USD","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757466","title":"Lb Pharmaceuticals - Topline Data from Phase 2 Trial in Adjunctive Mdd Expected in H1 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757466?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA4PWVRD:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757457","title":"Lb Pharmaceuticals - Expects Cash Runway into Q2 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757457","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757457?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA4PWVRD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757430","title":"Lb Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 Nova-2 Trial of Lb-102 in Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757430?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA4PWVRD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757102","title":"Lb Pharmaceuticals - to Report Phase 3 Nova-2 Topline Results in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757102?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA4PWVRD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653482757","title":"Lb Pharmaceuticals - Topline Data from Phase 2 Illuminate-1 in Bipolar Depression Expected in Q1 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2653482757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653482757?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:00","pubTimestamp":1784721602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA4PWVRD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653427942","title":"Lb Pharmaceuticals Inc : Bmo Initiates Coverage with Outperform Rating; Target Price $46","url":"https://stock-news.laohu8.com/highlight/detail?id=2653427942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653427942?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:49","pubTimestamp":1784630990,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653437273","title":"LB Pharmaceuticals Initiated at Outperform by BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2653437273","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653437273?lang=en_us&edition=fundamental","pubTime":"2026-07-21 17:43","pubTimestamp":1784626980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings(END) Dow Jones NewswiresJuly 21, 2026 05:43 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB","BMO","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650137199","title":"LB Pharmaceuticals Grants SVP Zergebel Option for 75,000 Shares at $32.95 Under NASDAQ Inducement Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2650137199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650137199?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:39","pubTimestamp":1783715982,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals grants SVP Zergebel option for 75,000 shares at $32.95 under Nasdaq inducement ruleLB Pharmaceuticals granted new SVP Clinical Operations Christopher Zergebel a stock option for 75,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL21tbY7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014021.USD","SG9999014039.USD","SG9999014013.SGD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4588","LU2095319765.USD","BCDF","NDAQ","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","BK4585","LBRX","LU0314104364.USD","SG9999014005.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650137975","title":"Lb Pharmaceuticals Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650137975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650137975?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:38","pubTimestamp":1783715938,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nTUA9WQGXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650137122","title":"Press Release: LB Pharmaceuticals Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650137122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650137122?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:38","pubTimestamp":1783715880,"startTime":"0","endTime":"0","summary":"NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (\"LB Pharmaceuticals\" or the \"Company\") (Nasdaq: LBRX), today announced that it has granted to Christopher Zergebel, the new Senior V","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPIQ","QDTE","PSQ","SQQQ","TECS","LB","QQQY","BK4233","LBRX","QID","FTEC","ONEQ","TQQQ","NQmain","QQQ","QQQM","NVIW.SI","MNQmain","IYW",".IXIC","JEPQ","QQQJ","BK4213","QYLG","NDX","QQQE","BK4007","QLD","TQQY","QQQA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649981162","title":"LB Pharmaceuticals Initiated at Outperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2649981162","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649981162?lang=en_us&edition=fundamental","pubTime":"2026-07-07 18:50","pubTimestamp":1783421400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings(END) Dow Jones NewswiresJuly 07, 2026 06:50 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647055397","title":"Lb Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2647055397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647055397?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:00","pubTimestamp":1782820802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUA3KC6M3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647055312","title":"Press Release: LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2647055312","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647055312?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:00","pubTimestamp":1782820800,"startTime":"0","endTime":"0","summary":"NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (\"LB Pharmaceuticals\" or the \"Company\") (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizop","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LB","BK4233","LBRX","BK4213"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":85,"code":"91000000","status":"200"}]}}